Embecta (STU:JX7) Inventories, Finished Goods: €110.8 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:JX7 Embecta Corp STU:JX7
52 GF Score
Price €4.12
GF Value €9.74
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Embecta Inventories, Finished Goods?

Embecta STU:JX7 +0.59% 52 Inventories, Finished Goods is €110.8 Mil as of Jun. 2026. GuruFocus rates STU:JX7 with a GF Score™ of 52/100 and a GF Value™ of €9.74 (Possible Value Trap). The stock has 6 warning signs investors should review.

Embecta's quarterly finished goods increased from Dec. 2025 (€98.3 Mil) to Mar. 2026 (€109.7 Mil) and increased from Mar. 2026 (€109.7 Mil) to Jun. 2026 (€110.8 Mil).

Embecta's annual finished goods increased from Sep. 2023 (€104.9 Mil) to Sep. 2024 (€113.8 Mil) but then declined from Sep. 2024 (€113.8 Mil) to Sep. 2025 (€99.6 Mil).

Embecta Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for Embecta's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Embecta Inventories, Finished Goods Chart

Embecta Annual Data
Trend Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Inventories, Finished Goods
Get a 7-Day Free Trial 71.32 94.74 104.85 113.80 99.60

Embecta Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 111.93 99.60 98.30 109.68 110.84
STU:JX7
52GF Score
Embecta Corp STU:JX7
Inventories, Finished Goods is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Embecta Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of €110.8 Mil mean?
Embecta (STU:JX7) has a Inventories, Finished Goods of €110.8 Mil as of Jun. 2026. Finished goods are inventory items that are complete and ready to be sold. View historical data on Embecta and its competitors.
Is Embecta's Inventories, Finished Goods too high?
Embecta's current Inventories, Finished Goods is €110.8 Mil. Overall, Embecta has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Embecta's Inventories, Finished Goods compare to UTMD and PDEX?
Embecta's Inventories, Finished Goods of €110.8 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Medical Devices & Instruments company?
A good Inventories, Finished Goods depends on the Medical Devices & Instruments industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Embecta and its competitors. Embecta's current Inventories, Finished Goods is €110.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Embecta stock overvalued right now?
Based on GuruFocus' analysis, Embecta (STU:JX7) is currently considered Possible Value Trap. The stock's GF Value™ is €9.74, compared to a current price of €4.12 — trading 57.7% below its estimated fair value. The current Inventories, Finished Goods is €110.8 Mil. Embecta's overall GF Score™ is 52/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Embecta (STU:JX7), the current Inventories, Finished Goods is €110.8 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Embecta (STU:JX7) Overvalued in 2026?

Based on GuruFocus' analysis, Embecta stock appears to be undervalued. The current stock price of €4.12 is trading 57.7% below its estimated GF Value™ of €9.74. GuruFocus considers Embecta to be Possible Value Trap.

Key valuation signals for STU:JX7:

  • Inventories, Finished Goods: €110.8 Mil
  • GF Value™: €9.74 vs. price of €4.12 (57.7% below fair value)
  • GF Score™: 52/100 with 6 warning signs

No single metric tells the full story. See the STU:JX7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Embecta Business Description

Other Exchanges EMBC:USA
Address 300 Kimball Drive, Suite 300, Parsippany, NJ, USA, 07054
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
52GF Score

Get the complete analysis for STU:JX7

Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.12
Price
€9.74
GF Value